Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Amongst sufferers with PD-1/PD-L1-pretreated recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), remedy with buparlisib and paclitaxel was not related to an...
Amongst sufferers with operable, newly recognized mind metastases, remedy with GammaTile was related to a higher than 50% discount within the danger...
Including VCN-01 (zabilugene almadenorepvec) to standard-of-care (SOC) gemcitabine plus Abraxane (nab-paclitaxel) led to improved total survival (OS), progression-free survival (PFS), and length...
